Wu, Chuntao <br/><br/>
Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.  [electronic resource] 

 -  Clinical therapeutics  03 2018 
 - 450-455.e1 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1879-114X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2018.01.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Amiodarone--adverse effects<br/>Anti-Arrhythmia Agents--adverse effects<br/>Atrial Fibrillation--drug therapy<br/>Cohort Studies<br/>Databases, Factual<br/>Dronedarone--administration & dosage<br/>Female<br/>Flecainide--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Peripheral Nervous System Diseases--chemically induced<br/>Propafenone--adverse effects<br/>Retrospective Studies<br/>Sotalol--administration & dosage